42 Poster Discussion - Tumor drug exposure is positively correlated with an improved outcome, in patients with advanced solid tumors, upon treatment with a high dose intermittent sunitinib regimen.
Saved in:
| Title: | 42 Poster Discussion - Tumor drug exposure is positively correlated with an improved outcome, in patients with advanced solid tumors, upon treatment with a high dose intermittent sunitinib regimen. |
|---|---|
| Authors: | Gerritse, S.1 (AUTHOR), ter Heine, R.2 (AUTHOR), Labots, M.3 (AUTHOR), van den Hombergh, E.2 (AUTHOR), Dekker, H.3 (AUTHOR), Lehutová, D.3 (AUTHOR), Rudek, M.4 (AUTHOR), van Erp, N.2 (AUTHOR), Verheul, H.1 (AUTHOR) |
| Source: | European Journal of Cancer. 2020 Supplement 2, Vol. 138, pS19-S19. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 148120226 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 42 Poster Discussion - Tumor drug exposure is positively correlated with an improved outcome, in patients with advanced solid tumors, upon treatment with a high dose intermittent sunitinib regimen. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Gerritse%2C+S%2E%22">Gerritse, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22ter+Heine%2C+R%2E%22">ter Heine, R.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Labots%2C+M%2E%22">Labots, M.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+den+Hombergh%2C+E%2E%22">van den Hombergh, E.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dekker%2C+H%2E%22">Dekker, H.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lehutová%2C+D%2E%22">Lehutová, D.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rudek%2C+M%2E%22">Rudek, M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+Erp%2C+N%2E%22">van Erp, N.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Verheul%2C+H%2E%22">Verheul, H.</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Cancer%22">European Journal of Cancer</searchLink>. 2020 Supplement 2, Vol. 138, pS19-S19. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=148120226 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0959-8049(20)31114-X Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S19 Titles: – TitleFull: 42 Poster Discussion - Tumor drug exposure is positively correlated with an improved outcome, in patients with advanced solid tumors, upon treatment with a high dose intermittent sunitinib regimen. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gerritse, S. – PersonEntity: Name: NameFull: ter Heine, R. – PersonEntity: Name: NameFull: Labots, M. – PersonEntity: Name: NameFull: van den Hombergh, E. – PersonEntity: Name: NameFull: Dekker, H. – PersonEntity: Name: NameFull: Lehutová, D. – PersonEntity: Name: NameFull: Rudek, M. – PersonEntity: Name: NameFull: van Erp, N. – PersonEntity: Name: NameFull: Verheul, H. IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 10 Text: 2020 Supplement 2 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 09598049 Numbering: – Type: volume Value: 138 Titles: – TitleFull: European Journal of Cancer Type: main |
| ResultId | 1 |
